Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group von Simkens, Lieke H J, MD, van Tinteren, Harm, PhD, May, Anne, PhD, ten Tije, Albert J, MD, Creemers, Geert-Jan M, MD, Loosveld, Olaf J L, MD, de Jongh, Felix E, MD, Erdkamp, Frans L G, MD, Erjavec, Zoran, MD, van der Torren, Adelheid M E, MD, Tol, Jolien, MD, Braun, Hans J J, MD, Nieboer, Peter, MD, van der Hoeven, Jacobus J M, Prof, Haasjes, Janny G, MD, Jansen, Rob L H, MD, Wals, Jaap, MD, Cats, Annemieke, MD, Derleyn, Veerle A, MD, Honkoop, Aafke H, MD, Mol, Linda, MSc, Punt, Cornelis J A, Prof, Koopman, Miriam, Dr

Volltext

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer von Kruijff, Ingeborg E., Sieuwerts, Anieta M., Onstenk, Wendy, Jager, Agnes, Hamberg, Paul, Jongh, Felix E., Smid, Marcel, Kraan, Jaco, Timmermans, Mieke A., Martens, John W. M., Sleijfer, Stefan

Volltext

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study von VON MINCKWITZ, Gunter, DU BOIS, Andreas, BAUMANN, Klaus H, CLEMENS, Michael R, DUERR, Ralph, ULEER, Christoph, ANDERSSON, Michael, STEIN, Robert C, NEKIJUDOVA, Valentina, LOIBL, Sibylle, SCHMIDT, Marcus, MAASS, Nicolai, CUFER, Tanja, DE JONGH, Felix E, MAARTENSE, Eduard, ZIELINSKI, Christoph, KAUFMANN, Manfred, BAUER, Wolfgang

Volltext

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients von Beije, Nick, Sieuwerts, Anieta M., Kraan, Jaco, Van, Ngoc M., Onstenk, Wendy, Vitale, Silvia R., Vlugt‐Daane, Michelle, Dirix, Luc Y., Brouwer, Anja, Hamberg, Paul, Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Jansen, Maurice P. H. M., Foekens, John A., Martens, John W. M., Sleijfer, Stefan

Volltext

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients von Kurk, Sophie, Peeters, Petra, Stellato, Rebecca, Dorresteijn, B., Jong, Pim, Jourdan, Marion, Creemers, Geert‐Jan, Erdkamp, Frans, Jongh, Felix, Kint, Peter, Simkens, Lieke, Tanis, Bea, Tjin‐A‐Ton, Manuel, Van Der Velden, Ankie, Punt, Cornelis, Koopman, Miriam, May, Anne

Volltext

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer von von Minckwitz, Gunter, Schwedler, Kathrin, Schmidt, Marcus, Barinoff, Jana, Mundhenke, Christoph, Cufer, Tanja, Maartense, Eduard, de Jongh, Felix E, Baumann, Klaus H, Bischoff, Joachim, Harbeck, Nadia, Lück, Hans-Joachim, Maass, Nicolai, Zielinski, Christoph, Andersson, Michael, Stein, Robert C, Nekljudova, Valentina, Loibl, Sibylle

Volltext

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients von SIEUWERTS, Anieta M, MOSTERT, Bianca, KRAAN, Jaco, VAN DER SPOEL, Petra, RAMIREZ-MORENO, Raquel, VAN DEURZEN, Carolien H. M, SMID, Marcel, YU, Jack X, JIANG, John, YIXIN WANG, GRATAMA, Jan W, SLEIJFER, Stefan, BOLT-DE VRIES, Joan, FOEKENS, John A, MARTENS, John W. M, PEETERS, Dieter, DE JONGH, Felix E, STOUTHARD, Jacqueline M. L, DIRIX, Luc Y, VAN DAM, Peter A, VAN GALEN, Anne, DE WEERD, Vanja

Volltext

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor von Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M, Hamberg, Paul, Dirix, Luc Y, Brouwer, Anja, de Jongh, Felix E, Jager, Agnes, Seynaeve, Caroline M, Van, Ngoc M, Foekens, John A, Martens, John W.M, Sleijfer, Stefan

Volltext

Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands von de Jongh, Felix E., Efe, Reva, Herrmann, Kirsten H., Spoorendonk, Jelle A.

Volltext

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands von Simons, Martijn J H G, Machielsen, Peter M, Spoorendonk, Jelle A, Ignacio, Tim, Drost, Pieter B, Jacobs, Tim, de Jongh, Felix E

Volltext

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial von Kurk, Sophie A., Peeters, Petra H. M., Dorresteijn, Bram, Jong, Pim A., Jourdan, Marion, Creemers, Geert‐Jan M., Erdkamp, Frans L. G., Jongh, Felix E., Kint, Peter A. M., Poppema, Boelo J., Radema, Sandra A., Simkens, Lieke H. J., Tanis, Bea C., Tjin‐A‐Ton, Manuel L. R., Van Der Velden, Ankie, Punt, Cornelis J. A., Koopman, Miriam, May, Anne M.

Volltext

Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer von Onstenk, Wendy, Sieuwerts, Anieta M, Weekhout, Marleen, Mostert, Bianca, Reijm, Esther A, van Deurzen, Carolien H.M, Bolt-de Vries, Joan B, Peeters, Dieter J, Hamberg, Paul, Seynaeve, Caroline, Jager, Agnes, de Jongh, Felix E, Smid, Marcel, Dirix, Luc Y, Kehrer, Diederik F.S, van Galen, Anne, Ramirez-Moreno, Raquel, Kraan, Jaco, Van, Mai, Gratama, Jan W, Martens, John W.M, Foekens, John A, Sleijfer, Stefan

Volltext

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment von DE GRAAN, Anne-Joy M, TEUNISSEN, Sebastiaan F, SEYNAEVE, Caroline, BEIJNEN, Jos H, MATHIJSSEN, Ron H. J, DE VOS, Filip Y. F. L, LOOS, Walter J, VAN SCHAIK, Ron H. N, DE JONGH, Felix E, DE VOS, Aad I, VAN ALPHEN, Robbert J, VAN DER HOLT, Bronno, VERWEIJ, Jaap

Volltext

An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA von Vitale, Silvia R., Sieuwerts, Anieta M., Beije, Nick, Kraan, Jaco, Angus, Lindsay, Mostert, Bianca, Reijm, Esther A., Van, Ngoc M., van Marion, Ronald, Dirix, Luc Y., Hamberg, Paul, de Jongh, Felix E., Jager, Agnes, Foekens, John A., Vigneri, Paolo, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M.

Volltext

Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline‐treated breast cancer patients von Broeyer, Frederik J. F., Osanto, Susanne, Suzuki, Jun, Jongh, Felix, Slooten, Henk, Tanis, Bea C., Bruning, Tobias, Bax, Jeroen J., Ritsema van Eck, Henk J., Kam, Marieke L., Cohen, Adam F., Mituzhima, Yutaka, Burggraaf, Jacobus

Volltext

The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial von Konings, Inge R.H.M, van der Gaast, A, van der Wijk, Lidemarie J, de Jongh, Felix E, Eskens, Ferry A.L.M, Sleijfer, Stefan

Volltext

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients von Reijm, Esther A, Sieuwerts, Anieta M, Smid, Marcel, Vries, Joan Bolt-de, Mostert, Bianca, Onstenk, Wendy, Peeters, Dieter, Dirix, Luc Y, Seynaeve, Caroline M, Jager, Agnes, de Jongh, Felix E, Hamberg, Paul, van Galen, Anne, Kraan, Jaco, Jansen, Maurice P H M, Gratama, Jan W, Foekens, John A, Martens, John W M, Berns, Els M J J, Sleijfer, Stefan

Volltext

Neutrophil-guided dosing of anthracycline–cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study von Drooger, Jan C., van Pelt-Sprangers, Johanna M., Leunis, Corry, Jager, Agnes, de Jongh, Felix E.

Volltext

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure von DE JONGH, Felix E, VERWEIJ, Jaap, LOOS, Walter J, DE WIT, Ronald, DE JONGE, Maja J. A, PLANTING, André S. T, NOOTER, Kees, STOTER, Gerrit, SPARREBOOM, Alex

Volltext

Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma von Elderman, Jan H, Wabbijn, Marike, de Jongh, Felix

Volltext